drugset / Trial / NCT03576690
R3470-3471-3479 (REGN-EB3) Expanded Access Protocol (EAP) for Treatment of Ebola Virus Disease
Summary
Provide access to REGN-EB3 for the treatment of patients with Ebola Virus Disease (EVD).
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Inmazeb | Monoclonal antibody | — | — |